These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Assessment of changes in utilization of health-care services after implementation of a prior authorization policy for atypical antipsychotic agents. Walthour A; Seymour L; Tackett R; Perri M Ann Pharmacother; 2010 May; 44(5):809-18. PubMed ID: 20388858 [TBL] [Abstract][Full Text] [Related]
6. Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder. Zhang Y; Adams AS; Ross-Degnan D; Zhang F; Soumerai SB Psychiatr Serv; 2009 Apr; 60(4):520-7. PubMed ID: 19339328 [TBL] [Abstract][Full Text] [Related]
7. Spillover effects of state medicaid antipsychotic prior authorization policies in US commercially insured youth. Spence O; Reeves G; dosReis S Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1064-1071. PubMed ID: 32558177 [TBL] [Abstract][Full Text] [Related]
8. Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics. Vogt WB; Joyce G; Xia J; Dirani R; Wan G; Goldman DP Health Aff (Millwood); 2011 Dec; 30(12):2346-54. PubMed ID: 22147863 [TBL] [Abstract][Full Text] [Related]
9. Medicaid Enrollment among Prison Inmates in a Non-expansion State: Exploring Predisposing, Enabling, and Need Factors Related to Enrollment Pre-incarceration and Post-Release. Grodensky CA; Rosen DL; Blue CM; Miller AR; Bradley-Bull S; Powell WA; Domino ME; Golin CE; Wohl DA J Urban Health; 2018 Aug; 95(4):454-466. PubMed ID: 29934825 [TBL] [Abstract][Full Text] [Related]
10. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study. Law MR; Lu CY; Soumerai SB; Graves AJ; LeCates RF; Zhang F; Ross-Degnan D; Adams AS Clin Ther; 2010 Apr; 32(4):729-41; discussion 716. PubMed ID: 20435243 [TBL] [Abstract][Full Text] [Related]
11. Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy review. Fischer MA; Cheng H; Schneeweiss S; Avorn J; Solomon DH Med Care; 2006 Jul; 44(7):658-63. PubMed ID: 16799360 [TBL] [Abstract][Full Text] [Related]
12. Impact of the Florida Medicaid prior-authorization program on use of antipsychotics by children under age six. Constantine R; Bengtson MA; Murphy T; McPherson M; Andel R; Jones ME; Donaldson-Guenther C Psychiatr Serv; 2012 Dec; 63(12):1257-60. PubMed ID: 23203363 [TBL] [Abstract][Full Text] [Related]
13. Medication continuity among Medicaid beneficiaries with schizophrenia and bipolar disorder. Brown JD; Barrett A; Caffery E; Hourihan K; Ireys HT Psychiatr Serv; 2013 Sep; 64(9):878-85. PubMed ID: 23728475 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic prescribing patterns in the Texas prison system. Baillargeon J; Contreras SA J Am Acad Psychiatry Law; 2001; 29(1):48-53. PubMed ID: 11302386 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors. Sankaranarayanan J; Puumala SE Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297 [TBL] [Abstract][Full Text] [Related]
16. Differences in the cost of antidepressants across state Medicaid programs. Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875 [TBL] [Abstract][Full Text] [Related]
17. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. Fischer MA; Schneeweiss S; Avorn J; Solomon DH N Engl J Med; 2004 Nov; 351(21):2187-94. PubMed ID: 15548779 [TBL] [Abstract][Full Text] [Related]
18. The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states. Stein BD; Leckman-Westin E; Okeke E; Scharf DM; Sorbero M; Chen Q; Chor KH; Finnerty M; Wisdom JP J Child Adolesc Psychopharmacol; 2014 Sep; 24(7):374-81. PubMed ID: 25144909 [TBL] [Abstract][Full Text] [Related]
19. Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness. Lu CY; Soumerai SB; Ross-Degnan D; Zhang F; Adams AS Med Care; 2010 Jan; 48(1):4-9. PubMed ID: 19956079 [TBL] [Abstract][Full Text] [Related]
20. Use of antipsychotic medications in treating schizophrenia among different financing and delivery systems. Bloom JR; Cheng JS; Hu TW; Kang SH; Wallace N J Ment Health Policy Econ; 2003 Dec; 6(4):163-71. PubMed ID: 14713723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]